526953 Stock Overview
Venus Remedies Limited engages in the development and marketing of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Venus Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹328.30 |
| 52 Week High | ₹429.60 |
| 52 Week Low | ₹185.65 |
| Beta | 1.08 |
| 1 Month Change | 7.67% |
| 3 Month Change | -12.42% |
| 1 Year Change | 64.93% |
| 3 Year Change | 4.77% |
| 5 Year Change | 925.94% |
| Change since IPO | 766.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526953 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.2% | 1.4% | 2.8% |
| 1Y | 64.9% | 57.2% | 46.6% |
Return vs Industry: 526953 exceeded the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 526953 exceeded the Indian Market which returned 46.6% over the past year.
Price Volatility
| 526953 volatility | |
|---|---|
| 526953 Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 526953 has not had significant price volatility in the past 3 months.
Volatility Over Time: 526953's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 998 | Ashutosh Jain | www.venusremedies.com |
Venus Remedies Limited engages in the development and marketing of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin care, wound management, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It is also involved in the provision of anti-infective, anticoagulant, and a portfolio of herbal products.
Venus Remedies Limited Fundamentals Summary
| 526953 fundamental statistics | |
|---|---|
| Market cap | ₹4.39b |
| Earnings (TTM) | ₹290.26m |
| Revenue (TTM) | ₹5.62b |
15.1x
P/E Ratio0.8x
P/S RatioIs 526953 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526953 income statement (TTM) | |
|---|---|
| Revenue | ₹5.62b |
| Cost of Revenue | ₹3.22b |
| Gross Profit | ₹2.40b |
| Other Expenses | ₹2.11b |
| Earnings | ₹290.26m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 21.71 |
| Gross Margin | 42.76% |
| Net Profit Margin | 5.17% |
| Debt/Equity Ratio | 8.9% |
How did 526953 perform over the long term?
See historical performance and comparison